Sanofi Share Price

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris 09:07:02 26/04/2024 pm IST 5-day change 1st Jan Change
91.23 EUR -0.43% Intraday chart for Sanofi +4.99% +1.64%

Financials

Sales 2024 * 46.11B 49.3B 4,112B Sales 2025 * 49.91B 53.37B 4,451B Capitalization 114B 122B 10,159B
Net income 2024 * 6.86B 7.33B 612B Net income 2025 * 8.62B 9.21B 768B EV / Sales 2024 * 2.59 x
Net Debt 2024 * 5.65B 6.04B 504B Net Debt 2025 * 2.37B 2.53B 211B EV / Sales 2025 * 2.33 x
P/E ratio 2024 *
16.4 x
P/E ratio 2025 *
13.3 x
Employees 86,088
Yield 2024 *
4.15%
Yield 2025 *
4.46%
Free-Float 87.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.43%
1 week+4.99%
Current month+0.30%
1 month-0.08%
3 months-0.92%
6 months-9.19%
Current year+1.64%
More quotes
1 week
86.74
Extreme 86.74
92.56
1 month
85.07
Extreme 85.07
92.56
Current year
84.93
Extreme 84.93
96.50
1 year
80.60
Extreme 80.6
104.32
3 years
76.45
Extreme 76.45
106.66
5 years
67.65
Extreme 67.65
106.66
10 years
62.50
Extreme 62.5
106.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01/19/01
Chief Operating Officer 39 01/22/01
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Director/Board Member 70 01/14/01
Director/Board Member 62 28/20/28
Director/Board Member 64 22/20/22
More insiders
Date Price Change Volume
26/24/26 91.23 -0.43% 1,682,358
25/24/25 91.62 +4.47% 3,378,063
24/24/24 87.7 -1.29% 1,576,217
23/24/23 88.85 +0.77% 1,062,952
22/24/22 88.17 +1.47% 1,454,519

Real-time Euronext Paris, April 26, 2024 at 09:07 pm IST

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
91.23 EUR
Average target price
107.9 EUR
Spread / Average Target
+18.26%
Consensus